共 35 条
[11]
The EGFR as a target for anticancer therapy-focus on cetuximab. Baselga J. European Journal of Cancer . 2001
[12]
Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. Mendelsohn J,Baselga J. Journal of Clinical Oncology . 2003
[13]
EGFR mutaions and EGFR tyrosine kinase inhibition in non-small cell lung cancer. Miller VA. Seminars in Oncology . 2008
[14]
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Jig H,Li D,Chen L,et al. Cancer Cell . 2006
[15]
Epidermal growth factor receptor pathway inhibitors. Baselga J. Update Cancer Ther . 2006
[16]
Epidermal growth factor receptor messenger RNA expression, gene dosage, and Gefitinib sensitivity in non-small cell lung cancer. Dziadziuszko R,,Witta SE,Cappuzzo F et al. Clinical Cancer Research . 2006
[17]
Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Dutta PR,Maity A. Cancer Letters . 2007
[18]
Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Dutta PR,Maity A. Cancer Letters . 2007
[19]
Detection of epidermal growth receptor factor in the serum of patients with cervical carcinoma. Oh MJ,Choi JH,Kim IH,et a1. Clinical Cancer Research . 2000
[20]
Im-pact of EGFR mutation analysis in non-small cell lung cancer. Hiromasa Yamamoto,Shinichi Toyooka,Tetsuya Mitsudomi. Lung Cancer . 2008